107 related articles for article (PubMed ID: 18812163)
1. AMPKalpha2 counteracts the development of cardiac hypertrophy induced by isoproterenol.
Zarrinpashneh E; Beauloye C; Ginion A; Pouleur AC; Havaux X; Hue L; Viollet B; Vanoverschelde JL; Bertrand L
Biochem Biophys Res Commun; 2008 Nov; 376(4):677-81. PubMed ID: 18812163
[TBL] [Abstract][Full Text] [Related]
2. AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice.
Zhang P; Hu X; Xu X; Fassett J; Zhu G; Viollet B; Xu W; Wiczer B; Bernlohr DA; Bache RJ; Chen Y
Hypertension; 2008 Nov; 52(5):918-24. PubMed ID: 18838626
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress induces GLUT4 translocation by activation of PI3-K/Akt and dual AMPK kinase in cardiac myocytes.
Horie T; Ono K; Nagao K; Nishi H; Kinoshita M; Kawamura T; Wada H; Shimatsu A; Kita T; Hasegawa K
J Cell Physiol; 2008 Jun; 215(3):733-42. PubMed ID: 18163380
[TBL] [Abstract][Full Text] [Related]
4. Functional role of AMP-activated protein kinase in the heart during exercise.
Musi N; Hirshman MF; Arad M; Xing Y; Fujii N; Pomerleau J; Ahmad F; Berul CI; Seidman JG; Tian R; Goodyear LJ
FEBS Lett; 2005 Apr; 579(10):2045-50. PubMed ID: 15811316
[TBL] [Abstract][Full Text] [Related]
5. Akt activation protects pancreatic beta cells from AMPK-mediated death through stimulation of mTOR.
Cai Y; Wang Q; Ling Z; Pipeleers D; McDermott P; Pende M; Heimberg H; Van de Casteele M
Biochem Pharmacol; 2008 May; 75(10):1981-93. PubMed ID: 18377870
[TBL] [Abstract][Full Text] [Related]
6. Integrin-linked kinase expression is elevated in human cardiac hypertrophy and induces hypertrophy in transgenic mice.
Lu H; Fedak PW; Dai X; Du C; Zhou YQ; Henkelman M; Mongroo PS; Lau A; Yamabi H; Hinek A; Husain M; Hannigan G; Coles JG
Circulation; 2006 Nov; 114(21):2271-9. PubMed ID: 17088456
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone attenuates cardiac hypertrophy in rats with salt-sensitive hypertension: role of activation of AMP-activated protein kinase and inhibition of Akt.
Kato MF; Shibata R; Obata K; Miyachi M; Yazawa H; Tsuboi K; Yamada T; Nishizawa T; Noda A; Cheng XW; Murate T; Koike Y; Murohara T; Yokota M; Nagata K
J Hypertens; 2008 Aug; 26(8):1669-76. PubMed ID: 18622247
[TBL] [Abstract][Full Text] [Related]
8. Lack of AMPKalpha2 enhances pyruvate dehydrogenase activity during exercise.
Klein DK; Pilegaard H; Treebak JT; Jensen TE; Viollet B; Schjerling P; Wojtaszewski JF
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1242-9. PubMed ID: 17711995
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of eEF2 and p70S6K by AMPKalpha2 in heart.
Demeulder B; Zarrinpashneh E; Ginion A; Viollet B; Hue L; Rider MH; Vanoverschelde JL; Beauloye C; Horman S; Bertrand L
Biochim Biophys Acta; 2013 Jun; 1832(6):780-90. PubMed ID: 23466593
[TBL] [Abstract][Full Text] [Related]
10. Macroarray analysis in the hypertrophic left ventricle of renin-dependent hypertensive rats: identification of target genes for renin.
Kurdi M; Cerutti C; Randon J; McGregor L; Bricca G
J Renin Angiotensin Aldosterone Syst; 2004 Jun; 5(2):72-8. PubMed ID: 15295718
[TBL] [Abstract][Full Text] [Related]
11. A distinct AMP-activated protein kinase phosphorylation site characterizes cardiac hypertrophy induced by L-thyroxine and angiotensin II.
Jiang SY; Xu M; Ma XW; Xiao H; Zhang YY
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):919-25. PubMed ID: 20497424
[TBL] [Abstract][Full Text] [Related]
12. Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy.
Jaffré F; Bonnin P; Callebert J; Debbabi H; Setola V; Doly S; Monassier L; Mettauer B; Blaxall BC; Launay JM; Maroteaux L
Circ Res; 2009 Jan; 104(1):113-23. PubMed ID: 19023134
[TBL] [Abstract][Full Text] [Related]
13. AMP-activated protein kinase alpha2 deficiency affects cardiac cardiolipin homeostasis and mitochondrial function.
Athéa Y; Viollet B; Mateo P; Rousseau D; Novotova M; Garnier A; Vaulont S; Wilding JR; Grynberg A; Veksler V; Hoerter J; Ventura-Clapier R
Diabetes; 2007 Mar; 56(3):786-94. PubMed ID: 17327449
[TBL] [Abstract][Full Text] [Related]
14. AMP-activated protein kinase regulates lymphocyte responses to metabolic stress but is largely dispensable for immune cell development and function.
Mayer A; Denanglaire S; Viollet B; Leo O; Andris F
Eur J Immunol; 2008 Apr; 38(4):948-56. PubMed ID: 18350549
[TBL] [Abstract][Full Text] [Related]
15. Induced adiposity and adipocyte hypertrophy in mice lacking the AMP-activated protein kinase-alpha2 subunit.
Villena JA; Viollet B; Andreelli F; Kahn A; Vaulont S; Sul HS
Diabetes; 2004 Sep; 53(9):2242-9. PubMed ID: 15331533
[TBL] [Abstract][Full Text] [Related]
16. AMPK alpha subunit gene characterization in Artemia and expression during development and in response to stress.
Zhu XJ; Feng CZ; Dai ZM; Zhang RC; Yang WJ
Stress; 2007 Mar; 10(1):53-63. PubMed ID: 17454967
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt.
Chan AY; Dolinsky VW; Soltys CL; Viollet B; Baksh S; Light PE; Dyck JR
J Biol Chem; 2008 Aug; 283(35):24194-201. PubMed ID: 18562309
[TBL] [Abstract][Full Text] [Related]
18. CYP2J2 and its metabolites (epoxyeicosatrienoic acids) attenuate cardiac hypertrophy by activating AMPKα2 and enhancing nuclear translocation of Akt1.
Wang B; Zeng H; Wen Z; Chen C; Wang DW
Aging Cell; 2016 Oct; 15(5):940-52. PubMed ID: 27416746
[TBL] [Abstract][Full Text] [Related]
19. Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction.
Ikeda Y; Sato K; Pimentel DR; Sam F; Shaw RJ; Dyck JR; Walsh K
J Biol Chem; 2009 Dec; 284(51):35839-49. PubMed ID: 19828446
[TBL] [Abstract][Full Text] [Related]
20. Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy.
Wang C; Li L; Zhang ZG; Fan D; Zhu Y; Wu LL
J Cell Physiol; 2010 Jan; 222(1):149-55. PubMed ID: 19780028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
